Sort
85,873 grants matching “alzheimers”
Clinical and Biological Studies of Early AD
$2,154,672Mount Sinai School Of Medicine Of Nyu · P01 · FY2005 · AG
Mild Cognitive Impairment: a Prospective Community Study
$2,154,423Mary Ganguli · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AG
Effects of apoE Isoform, Sex and Diet on Insulin Regulation in Brain
$2,153,894William A Banks · Seattle Inst For Biomedical/Clinical Res · RF1 · FY2018 · AG
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches
$2,153,560Anita L Destefano · Boston University Medical Campus · U01 · FY2021 · AG
The VETSA Longitudinal Twin Study of Cognition and Aging (VETSA 3)
$2,153,335William S Kremen · University Of California, San Diego · R01 · FY2017 · AG
Roles Of Brain Neuroimmune System In Neurodegeneration
$2,152,477Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES
APOE and microglia-mediated progression in tau pathology in AD
$2,151,974Tsuneya Ikezu · Mayo Clinic Jacksonville · RF1 · FY2021 · AG
Mapping the Causal Genetic-Imaging-Clinical Pathway for Alzheimer's Disease
$2,151,878Hongtu Zhu · Univ Of North Carolina Chapel Hill · RF1 · FY2023 · AG
Endocannabinoids in neurodegenerative diseases
$2,151,868Chu Chen · University Of Texas Hlth Science Center · RF1 · FY2023 · NS
Alzheimer Disease Research Center
$2,151,643University Of Southern California · P50 · FY2004 · AG
AD Immunotherapy with a Novel CDC-Mutant Anti-Pyroglutamate-3 Abeta Antibody to Avoid Vascular Side Effects
$2,151,385Cynthia A Lemere · Brigham And Women'S Hospital · RF1 · FY2018 · AG
Fine particulate matter exposure and small cerebrovascular inflammation
$2,151,314Zhenguo Liu · University Of Missouri-Columbia · RF1 · FY2023 · NS
Spatial-Temporal Characterization of The Hemodynamic Response to Neural Activity
$2,151,228Afonso Silva · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
Molecular signaling during development and maturation of the nervous system
$2,150,898David Talmage · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
$2,150,794Natalia S Rost · Massachusetts General Hospital · U19 · FY2022 · NS
Alzheimer's dementia onset and progression in international cohorts (Amended)
$2,150,430Colin Masters · University Of Melbourne · R01 · FY2019 · AG
Assessing the effectiveness of oral anticoagulants in patients with atrial fibrillation at high risk of underutilization due to dementia, recurrent falls, or poor anticoagulation quality
$2,150,379Joshua K Lin · Brigham And Women'S Hospital · RF1 · FY2019 · AG
Linking tau proteostasis with neuronal activity in FTD
$2,149,676Li Gan · Weill Medical Coll Of Cornell Univ · U54 · FY2018 · NS
Presenilin Biology and the Mechanisms of Alzheimer's Disease
$2,149,293Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2013 · AG
Alzheimer's Disease Research Center at Columbia Univ.
$2,148,866Michael Shelanski · Columbia University Health Sciences · P50 · FY2006 · AG
Optogenetic Study of ApoE4-Related Alzheimers Disease
$2,148,750Yadong Huang · J. David Gladstone Institutes · RF1 · FY2014 · AG
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease
$2,148,046Olga V Fedorova · National Institute On Aging · ZIA · FY2018 · AG
Imaging Pathophysiology in Aging and Neurodegeneration
$2,148,033Ann D. Cohen · University Of Pittsburgh At Pittsburgh · P01 · FY2020 · AG
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches
$2,147,504Anita L Destefano · Boston University Medical Campus · U01 · FY2022 · AG
University of Kentucky Alzheimer's Disease Core Center
$2,147,234Linda J Van Eldik · University Of Kentucky · P30 · FY2019 · AG